查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596152

即時PCR市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Real-time PCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Forensics, Research), End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年即時PCR市場估值為 34.4 億美元，預計 2024 年將達到 37.6 億美元，預計複合年成長率為 9.74%，到 2030 年將達到 66 億美元。

即時PCR也稱為定量 PCR (qPCR)，是一種強大的分子生物學技術，用於目標 DNA 分子的擴增和同步定量。此方法的準確性對於基因表現分析、病原體檢測、基因突變分析以及臨床診斷、生物技術、法醫學和實驗室等領域的核酸序列測量等應用至關重要。即時PCR因其能夠提供快速、準確和高效的結果而越來越受歡迎，這對於診斷感染疾病（包括 COVID-19 等流行病）越來越重要。由於基因組研究的進步、對永續農業的需求不斷增加以及個人化醫療的趨勢，該市場正在不斷擴大，從而推動了對準確遺傳評估的需求。關鍵的成長要素包括提高準確性和靈敏度的技術創新、政府對研發的資助增加以及對早期疾病檢測的認知提高。然而，設備成本高、對熟練人員的需求以及不同平台之間標準化程度有限等挑戰可能會阻礙成長。透過提高自動化程度、開發更具成本效益的設備以及擴展到實驗室基礎設施正在開發的開拓地區，機會將不斷擴大。潛在的創新在於 qPCR 與數位技術的整合、雲端基礎資料分析的便利性以及現場應用可攜式PCR 設備的進步。為了利用成長機會，公司應專注於多重技術和可攜式設備創新的研發投資。市場競爭呈現出充滿活力且未來性的軌跡，這主要是由技術進步和滿足診斷需求的競賽所推動的。調整策略以克服未發現的限制並瞄準新興趨勢可以推動永續成長和市場領導地位。

主要市場統計
基準年[2023] 34.4億美元
預測年份 [2024] 37.6億美元
預測年份 [2030] 66億美元
複合年成長率（%） 9.74%

市場動態：揭示快速發展的即時PCR市場的關鍵市場洞察

供應和需求的動態相互作用正在改變即時PCR市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病和遺傳疾病的流行
    • 快速利用生物標記分析進行疾病診斷
    • 早期診斷致病微生物並增加臨床診斷測試的使用
  • 市場限制因素
    • 即時PCR相關的設備成本較高
  • 市場機會
    • 持續技術整合和開發緊湊型、可攜式、實驗室晶片PC 設備
    • 從基於植物來源的藥物發現快速轉變為基於基因組的藥物發現
  • 市場挑戰
    • 即時PCR技術的技術限制和缺乏熟練的專家

波特五力：駕馭即時PCR市場的策略工具

波特五力框架是了解即時PCR市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解即時PCR市場的外部影響

外部宏觀環境因素在塑造即時PCR市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解即時PCR市場的競爭狀況

對即時PCR市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，使他們的公司能夠應對日益激烈的競爭。

FPNV定位矩陣即時PCR市場供應商績效評估

FPNV定位矩陣是評估即時PCR市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪即時PCR市場的成功之路

即時PCR市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病和遺傳疾病的傳播
      • 快速利用生物標記分析進行疾病診斷
      • 病原微生物的早期診斷和臨床診斷測試的增加使用
    • 抑制因素
      • 與即時PCR相關的高設備成本
    • 機會
      • 持續技術整合和開發緊湊型可攜式實驗室晶片單元
      • 從基於植物來源的藥物發現快速轉變為基於基因組的藥物發現
    • 任務
      • 即時PCR技術的技術限制和缺乏熟練的專家
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章即時PCR市場：依產品

  • 裝置
  • 試劑/耗材
  • 軟體和服務

第7章即時PCR市場：依應用分類

  • 臨床
  • 法醫學
  • 調查

第 8 章即時PCR市場：依最終用戶分類

  • 臨床研究組織
  • 法醫學研究所
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究實驗室和學術機構

第9章美洲即時PCR市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區即時PCR市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲即時PCR市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux Sweden AB
  • Bioneer Corporation
  • Danaher Corporation
  • ELITechGroup
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • QIAGEN GmbH
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0D217D5AEDAD

The Real-time PCR Market was valued at USD 3.44 billion in 2023, expected to reach USD 3.76 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 6.60 billion by 2030.

Real-time PCR, also known as quantitative PCR (qPCR), is a powerful molecular biology technique used for the amplification and simultaneous quantification of a targeted DNA molecule. This method is crucial for its precision in measuring nucleic acid sequences, fundamental in applications like gene expression analysis, pathogen detection, genetic variation analysis, and in areas such as clinical diagnostics, biotechnology, forensic science, and research laboratories. Real-time PCR is gaining traction due to its ability to deliver rapid, accurate, and efficient results, which is increasingly critical for diagnosing infectious diseases, including prevalent issues such as COVID-19. The market is expanding due to advancements in genomic research, a growing demand for sustainable agriculture practices, and personalized medicine trends, fueling the need for precise genetic assessments. Key growth factors include technological innovations improving accuracy and sensitivity, increased governmental funding for R&D, and rising awareness of early disease detection. However, challenges such as the high cost of equipment, the need for skilled personnel, and limitations in standardization across different platforms might hinder growth. Opportunities thrive in enhancing automation, developing more cost-effective devices, and expanding into untapped regions where laboratory infrastructure is developing. Potential innovations lie in integrating qPCR with digital technologies, promoting cloud-based data analytics, and advancing portable PCR devices for field applications. To capitalize on growth opportunities, firms should focus on R&D investments in multiplexing techniques and portable device innovations. The market is competitive, driven heavily by technological advancements and the race to meet diagnostic demands, indicating a dynamic and future-forward trajectory. Adjusting strategies to overcome identified limitations and targeting emerging trends can facilitate sustained growth and market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 3.44 billion
Estimated Year [2024] USD 3.76 billion
Forecast Year [2030] USD 6.60 billion
CAGR (%) 9.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Real-time PCR Market

The Real-time PCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of infectious diseases and genetic disorders
    • Rapid utilization of biomarker profiling for disease diagnostics
    • Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
  • Market Restraints
    • High device costs associated with real-time PCR
  • Market Opportunities
    • Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
    • Rapid shift from plant-derived to genome-based drug discovery
  • Market Challenges
    • Technical limitations of real-time PCR techniques and lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Real-time PCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Real-time PCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Real-time PCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Real-time PCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Real-time PCR Market

A detailed market share analysis in the Real-time PCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Real-time PCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Real-time PCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Real-time PCR Market

A strategic analysis of the Real-time PCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Real-time PCR Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Analytik Jena GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux Sweden AB, Bioneer Corporation, Danaher Corporation, ELITechGroup, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, QIAGEN GmbH, Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Real-time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Clinical, Forensics, and Research.
  • Based on End Users, market is studied across Clinical Research Organizations, Forensic Laboratories, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Laboratories & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Rapid utilization of biomarker profiling for disease diagnostics
      • 5.1.1.3. Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High device costs associated with real-time PCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
      • 5.1.3.2. Rapid shift from plant-derived to genome-based drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of real-time PCR techniques and lack of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Real-time PCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Real-time PCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical
  • 7.3. Forensics
  • 7.4. Research

8. Real-time PCR Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Diagnostic Centers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Laboratories & Academic Institutes

9. Americas Real-time PCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Real-time PCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Real-time PCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Analytik Jena GmbH
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux Sweden AB
  • 6. Bioneer Corporation
  • 7. Danaher Corporation
  • 8. ELITechGroup
  • 9. Enzo Life Sciences, Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Merck KGaA
  • 12. Promega Corporation
  • 13. QIAGEN GmbH
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. REAL-TIME PCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023